HPV-associated genital diseases: current diagnosis and treatment options

Optimizing the management of patients with HPV-associated cervical diseases remains a priority for the modern studies on this issue. The human papillomavirus is divided into two types: high-risk and low-risk types according to its malignant potential to cause cervical cancer and some other oncologic...

Full description

Bibliographic Details
Main Authors: E. R. Dovletkhanova, P. R. Abakarova
Format: Article
Language:Russian
Published: Remedium Group LLC 2020-04-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/5578
id doaj-5b0bda0f604943c4a4bd89a729f2dc57
record_format Article
spelling doaj-5b0bda0f604943c4a4bd89a729f2dc572021-07-28T13:29:45ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902020-04-010310711310.21518/2079-701X-2020-3-107-1135072HPV-associated genital diseases: current diagnosis and treatment optionsE. R. Dovletkhanova0P. R. Abakarova1National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. KulakovNational Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. KulakovOptimizing the management of patients with HPV-associated cervical diseases remains a priority for the modern studies on this issue. The human papillomavirus is divided into two types: high-risk and low-risk types according to its malignant potential to cause cervical cancer and some other oncological diseases. Human papillomavirus can clear spontaneously in 85-90% cases, but the risk of cervical intraepithelial neoplasia and invasive cervical cancer is quite high in persistent high-risk oncogenic infection. The virus presence in the body tissues cannot be considered as a marker for progression or regression of the pathological process in the strict sense, even though cervical intraepithelial neoplasia and cervical cancer develop in HPV-positive patients in the vast majority of cases. These studies are aimed at searching for the new and improving existing methods for early diagnosis of precancerous diseases and cervical cancer. The development of the HPV-associated pathological process is known to be dependent on the human immune system status. The virus provokes a cellular immune response, which is expressed as changes in interferon status, cytotoxic activity of natural killer cells, methylation processes, etc. The use of a holistic approach to treatment, a comdoibination of traditional therapy, antigen-specific vaccination and administration of immunomodulating agents seems relevant for patients with persistent high-risk oncogenic papilloma virus, as well as precancerous diseases and cervical cancer. The use of immunomodulators in the complex treatment of virus-associated diseases contributes to relief of symptoms and reduction of the recurrence rate.https://www.med-sovet.pro/jour/article/view/5578human papillomavirus infectioncervicovaginal fluidbiomarkershpv persistencemethylationhpv-associated diseases
collection DOAJ
language Russian
format Article
sources DOAJ
author E. R. Dovletkhanova
P. R. Abakarova
spellingShingle E. R. Dovletkhanova
P. R. Abakarova
HPV-associated genital diseases: current diagnosis and treatment options
Медицинский совет
human papillomavirus infection
cervicovaginal fluid
biomarkers
hpv persistence
methylation
hpv-associated diseases
author_facet E. R. Dovletkhanova
P. R. Abakarova
author_sort E. R. Dovletkhanova
title HPV-associated genital diseases: current diagnosis and treatment options
title_short HPV-associated genital diseases: current diagnosis and treatment options
title_full HPV-associated genital diseases: current diagnosis and treatment options
title_fullStr HPV-associated genital diseases: current diagnosis and treatment options
title_full_unstemmed HPV-associated genital diseases: current diagnosis and treatment options
title_sort hpv-associated genital diseases: current diagnosis and treatment options
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2020-04-01
description Optimizing the management of patients with HPV-associated cervical diseases remains a priority for the modern studies on this issue. The human papillomavirus is divided into two types: high-risk and low-risk types according to its malignant potential to cause cervical cancer and some other oncological diseases. Human papillomavirus can clear spontaneously in 85-90% cases, but the risk of cervical intraepithelial neoplasia and invasive cervical cancer is quite high in persistent high-risk oncogenic infection. The virus presence in the body tissues cannot be considered as a marker for progression or regression of the pathological process in the strict sense, even though cervical intraepithelial neoplasia and cervical cancer develop in HPV-positive patients in the vast majority of cases. These studies are aimed at searching for the new and improving existing methods for early diagnosis of precancerous diseases and cervical cancer. The development of the HPV-associated pathological process is known to be dependent on the human immune system status. The virus provokes a cellular immune response, which is expressed as changes in interferon status, cytotoxic activity of natural killer cells, methylation processes, etc. The use of a holistic approach to treatment, a comdoibination of traditional therapy, antigen-specific vaccination and administration of immunomodulating agents seems relevant for patients with persistent high-risk oncogenic papilloma virus, as well as precancerous diseases and cervical cancer. The use of immunomodulators in the complex treatment of virus-associated diseases contributes to relief of symptoms and reduction of the recurrence rate.
topic human papillomavirus infection
cervicovaginal fluid
biomarkers
hpv persistence
methylation
hpv-associated diseases
url https://www.med-sovet.pro/jour/article/view/5578
work_keys_str_mv AT erdovletkhanova hpvassociatedgenitaldiseasescurrentdiagnosisandtreatmentoptions
AT prabakarova hpvassociatedgenitaldiseasescurrentdiagnosisandtreatmentoptions
_version_ 1721273590953803776